Pro-inflammatory activities induced by CyPA-EMMPRIN interaction in monocytes

Atherosclerosis

Volumn 213, Issue 2, 2010, Pages 415-421

  Yuan, Wei ^a   Ge, Heng ^a   He, Ben ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Atherosclerosis; Cyclophilin A; EMMPRIN (extracellular matrix metalloproteinase inducer); Matrix metalloproteinase 9(MMP 9); Monocytes

Indexed keywords

CD147 ANTIGEN; CHEMOATTRACTANT; CYCLOPHILIN A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; WESTERN BLOTTING;

ANTIGENS, CD147; CELL LINE; CELL MOVEMENT; CYCLOPHILIN A; CYCLOSPORINE; EXTRACELLULAR MATRIX; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; INFLAMMATION; INTERLEUKIN-6; MACROPHAGES; MATRIX METALLOPROTEINASE 9; MONOCYTES; NF-KAPPA B; SIGNAL TRANSDUCTION;

EID: 78649724382     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.09.033     Document Type: Article

References (28)

1. 2 for platelet-derived growth factor signal transduction. Science 1995, 270:296-299.
2. Griendling K.K., Minieri C.A., Ollerenshaw J.D., et al. Angiotensin II stimulates NADH and NADPH oxidase activation in cultured vascular smooth muscle cells. Circ Res 1994, 74:1141-1148.
3. Stephens J.W., Khanolkar M.P., Bain S.C. The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease. Atherosclerosis 2009, 202(2):321-329.
4. Libby P., Ridker P.M. Novel inflammatory markers of coronary risk: theory versus practice. Circulation 1999, 100:1148-1150.
5. Sherry B., Yarlett N., Strupp A., Cerami A. Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide-activated macrophages. Proc Natl Acad Sci U S A 1992, 89:3511-3515.
6. Kim S.H., Lessner S.M., Sakurai Y., Galis Z.S., Cyclophilin A as a novel biphasic mediator of endothelial activation and dysfunction. Am J Pathol 2004, 164(5):1567-1574.
7. Suzuki J., Jin Z.G., Meoli D.F., Matoba T., Berk B.C. Cyclophilin A is secreted by a vesicular pathway in vascular smooth muscle cells. Circ Res 2006, 98(6):811-817.
8. Tegeder I., Schumacher A., John S., et al. Elevated serum Cyclophilin levels in patients with severe sepsis. J Clin Immunol 1997, 17(5):380-386.
9. Billich A., Winkler G., Aschauer H., et al. Presence of Cyclophilin A in synovial fluids of patients with rheumatioid arthritis. J Exp Med 1997, 185(5):975-980.
10. Satoh K., Matoba T., Suzuki J., et al. Cyclophilin A mediates vascular remodeling by promoting inflammation and vascular smooth muscle cell proliferation. Circulation 2008, 117:3088-3098.
11. Pushkarsky T., Zybarth G., Dubrovsky L., et al. CD147 facilitates HIV-1 infection by interacting with virus-associated Cyclophilin A. Proc Natl Acad Sci U S A 2001, 98:6360-6365.
12. Chen Z., Mi L., Xu J., et al. Function of HAB18g/CD147 in invasion of host cells by severe acute respiratory syndrome coronavirus. J Infect Dis 2005, 191:755-760.
13. Major T.C., Liang L., Lu X., Rosebury W., Bocan T.M. Extracellular matrix metalloproteinase inducer (EMMPRIN) is induced upon monocyte differentiation and is expressed in human atheroma. Arterioscler Thromb Vasc Biol 2002, 22:1200-1207.
14. YoonYW, Kwon H.M., Hwang K.C., et al. Upstream regulation of matrix metalloproteinase by EMMPRIN; extracellular matrix metalloproteinase inducer in advanced atherosclerotic plaque. Atherosclerosis 2005, 180:37-44.
15. Sluijter J.P., Pulskens W.P., Schoneveld A.H., et al. Matrix metalloproteinase 2 is associated with stable and matrix metalloproteinase 8 and 9 with vulnerable carotid atherosclerotic lesions: a study in human endarterectomy specimen pointing to a role for different extracelluar matrix metalloproteinase inducer glycosylation forms. Strock 2006, 37(1):235-239.
16. Zhang J., Ge H., Wang C., et al. Inhibitory effect of PPAR on the expression of EMMPRIN in macrophages and foam cells. Int J Cardiol 2007, 117(3):373-380.
17. Ge H., Zhang J., Guo B.S., et al. Resveratrol inhibits macrophage expression of EMMPRIN by activating PPARgamma. Vasc Pharmacol 2007, 46(2):114-121.
18. Payeli S.K., Schiene-Fischer C., Steffel J., et al. Cyclophilin A differentially activates monocytes and endothelial cells Role of purity, activity, and endotoxin contamination in commercial preparations. Atherosclerosis 2008, 197(2):564-571.
19. Jin Z.G., Lungu A.O., Xie L., Wang M., Wong C., Berk B.C. Cyclophilin A is a proinflammatory cytokine that activates endothelial cells. Arterioscler Thromb Vasc Biol 2004, 24(7):1186-1191.
20. Jin Z.G., Melaragno M.G., Liao D.F., et al. Cyclophilin A is a secreted growth factor induced by oxidative stress. Circ Res 2000, 87:789-796.
21. Galat A. Peptidylproline cis-trans-isomerases: immunophilins. Eur J Biochem 1993, 216(3):689-707.
22. Arora K., Gwinn W.M., Bower M.A., et al. Extracellular cyclophilins contribute to the regulation of inflammatory responses. J Immunol 2005, 175:517-522.
23. Yurchenko V., Zybarth G., O'Connor M., et al. Active site residues of Cyclophilin A are crucial for its signaling activity via CD147. J Biol Chem 2002, 277:22959-22965.
24. Lusis A.J. Atherosclerosis. Nature 2000, 407:233-241.
25. Libby P. Current concepts of the pathogenesis of acute coronary syndromes. Circulation 2002, 104:365-372.
26. Bordador L.C., Li X., Toole B., et al. Expression of EMMPRIN by oral squamous cell carcinoma. Int J Cancer 2000, 85:347-352.
27. Polette M., Gilles C., Marchand V., et al. Tumor collagenase sitmulatory factor (TCSF) expression and localization in human lung and breast cancers. J Histochem Cytochem 1997, 45:703-709.
28. Belton R.J., Chen L., Mesquita F.S., et al. Basigin-2 is a cell surface receptor for soluble basigin ligand. J Biol Chem 2008, 283(26):17805-17814.